share_log

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT:其他
美股SEC公告 ·  11/04 06:04

Moomoo AI 已提取核心訊息

Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119576 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-224809, marks a significant regulatory milestone for Tracon Pharmaceuticals.
Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119576 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-224809, marks a significant regulatory milestone for Tracon Pharmaceuticals.
tracon pharmaceuticals公司已於2024年11月1日收到了美國證券交易委員會(SEC)發出的生效通知。該通知以訪問編號0000950170-24-119576和提交類型pos am進行了標識,表明該公司的申報已被SEC正式接受。與文件號碼333-224809相關聯的申報的有效性,標誌着tracon pharmaceuticals公司的重要監管里程碑。
tracon pharmaceuticals公司已於2024年11月1日收到了美國證券交易委員會(SEC)發出的生效通知。該通知以訪問編號0000950170-24-119576和提交類型pos am進行了標識,表明該公司的申報已被SEC正式接受。與文件號碼333-224809相關聯的申報的有效性,標誌着tracon pharmaceuticals公司的重要監管里程碑。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息